Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,409 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DSM-5 criteria for substance use disorders: recommendations and rationale.
Hasin DS, O'Brien CP, Auriacombe M, Borges G, Bucholz K, Budney A, Compton WM, Crowley T, Ling W, Petry NM, Schuckit M, Grant BF. Hasin DS, et al. Among authors: ling w. Am J Psychiatry. 2013 Aug;170(8):834-51. doi: 10.1176/appi.ajp.2013.12060782. Am J Psychiatry. 2013. PMID: 23903334 Free PMC article. Review.
Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs?
Nunes EV, Ball S, Booth R, Brigham G, Calsyn DA, Carroll K, Feaster DJ, Hien D, Hubbard RL, Ling W, Petry NM, Rotrosen J, Selzer J, Stitzer M, Tross S, Wakim P, Winhusen T, Woody G. Nunes EV, et al. Among authors: ling w. J Subst Abuse Treat. 2010 Jun;38 Suppl 1(Suppl 1):S97-112. doi: 10.1016/j.jsat.2010.01.012. J Subst Abuse Treat. 2010. PMID: 20307801 Free PMC article.
A Phase 3 placebo-controlled, double-blind, multi-site trial of the alpha-2-adrenergic agonist, lofexidine, for opioid withdrawal.
Yu E, Miotto K, Akerele E, Montgomery A, Elkashef A, Walsh R, Montoya I, Fischman MW, Collins J, McSherry F, Boardman K, Davies DK, O'Brien CP, Ling W, Kleber H, Herman BH. Yu E, et al. Among authors: ling w. Drug Alcohol Depend. 2008 Sep 1;97(1-2):158-68. doi: 10.1016/j.drugalcdep.2008.04.002. Epub 2008 May 27. Drug Alcohol Depend. 2008. PMID: 18508207 Free PMC article. Clinical Trial.
Clinical pharmacokinetics of lofexidine, the alpha 2-adrenergic receptor agonist, in opiate addicts plasma using a highly sensitive liquid chromatography tandem mass spectrometric analysis.
Yu E, Miotto K, Akerele E, O'Brien CP, Ling W, Kleber H, Fischman MW, Elkashef A, Herman BH, Al-Ghananeem AM. Yu E, et al. Among authors: ling w. Am J Drug Alcohol Abuse. 2008;34(5):611-6. doi: 10.1080/00952990802308122. Am J Drug Alcohol Abuse. 2008. PMID: 18821454 Clinical Trial.
DSM-V: time for change.
Ling W. Ling W. Addiction. 2011 May;106(5):872-3; discussion 895-7. doi: 10.1111/j.1360-0443.2010.03343.x. Addiction. 2011. PMID: 21477229 No abstract available.
Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network.
Wu LT, Ling W, Burchett B, Blazer DG, Yang C, Pan JJ, Reeve BB, Woody GE. Wu LT, et al. Among authors: ling w. Drug Alcohol Depend. 2011 Nov 1;118(2-3):186-93. doi: 10.1016/j.drugalcdep.2011.03.018. Epub 2011 Apr 17. Drug Alcohol Depend. 2011. PMID: 21501933 Free PMC article.
1,409 results